North America leads the global alpha amylase assay kit market because of advanced healthcare infrastructure, high clinical diagnostic volumes, and strong R&D investment in enzyme-based therapeutics. Asia-Pacific is emerging as the fastest-growing region as hospital network expansion, diagnostic infrastructure investment, and pharmaceutical R&D increase. The alpha amylase assay kit...